Lisdexamfetamine Dimesylate — ingredient monograph

Overview

Source: NDC Directory

Ingredient name

LISDEXAMFETAMINE DIMESYLATE

Base moiety

LISDEXAMFETAMINE DIMESYLATE

RxNorm CUI

854830

UNII

SJT761GEGS

Medication products

9

Brand names

4

Dosage forms

4

FAERS reports

32,811 · not a risk measure

Products containing this ingredient

Source: NDC Directory 9 products

Di-tert-butyl ((S)-6-oxo-6-(((S)-1-phenylpropan-2-yl) amino) hexane-1,5-diyl) dicarbamate Powder
1 NDC
LDF 3A Ldf 3A · Powder
1 NDC
Lisdexamfetamine Dimesylate Powder
12 NDC
Lisdexfetamine Dimesylate Powder
1 NDC
ARYNTA lisdexamfetamine dimesylate oral · Solution
Rx NDA 5 NDC
LISDEXAMFETAMINE DIMESYLATE Lisdexamfetamine Dimesylate · Capsule
Rx ANDA TE AB 8 recalls 129 NDC
lisdexamfetamine dimesylate Tablet, Chewable
Rx ANDA TE AB 36 NDC
Vyvanse lisdexamfetamine dimesylate · Capsule
Rx NDA TE AB 1 recall 7 NDC
Vyvanse Lisdexamfetamine Dimesylate · Tablet, Chewable
Rx NDA TE AB 6 NDC

Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.

By dosage form

How this ingredient is presented across the catalogue.
Dosage form	Products	Examples
Powder	4	Di-tert-butyl ((S)-6-oxo-6-(((S)-1-phenylpropan-2-yl) amino) hexane-1,5-diyl) dicarbamate, LDF 3A, Lisdexamfetamine Dimesylate, Lisdexfetamine Dimesylate
Capsule	2	LISDEXAMFETAMINE DIMESYLATE, Vyvanse
TABLET, Chewable	2	lisdexamfetamine dimesylate, Vyvanse
Solution	1	ARYNTA

Sources for this page

Dataset	Agency	Used for
NDC Directory	FDA	Ingredient name, strengths, products, labelers, packages
DailyMed RxNorm mappings	NLM	RxNorm concept identifier (RxCUI)
FAERS	FDA	Adverse event report totals